Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL
Clinical trial NCT06062641 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06062641
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2024-04-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.